Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
09/11/2009 | WO2009111056A1 Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
09/11/2009 | WO2009110985A2 Amide compounds, compositions and uses thereof |
09/11/2009 | WO2009110475A1 Process for production of 3-amino-2-chloro-6- trifluoromethylpyridine |
09/11/2009 | WO2009110217A1 Hydroxyapatite with silver supported on the surface thereof |
09/11/2009 | WO2009109570A1 Inhibitors for brassinosteroid signalling |
09/11/2009 | WO2009048152A3 Unsaturated imine compound and use thereof for pest control |
09/11/2009 | CA2717069A1 Pesticides |
09/11/2009 | CA2716949A1 N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer |
09/11/2009 | CA2716352A1 Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
09/11/2009 | CA2715835A1 Amide compounds, compositions and uses thereof |
09/11/2009 | CA2712589A1 Inhibitors for brassinosteroid signalling |
09/10/2009 | US20090227790 A kit for treating a disorder characterized by loss of dopaminergic and/or motoneurons, for treating Parkinson's disease, amyotrophic lateral sclerosis (ALS), or limiting damage to neuronal cells by Parkinsonian conditions |
09/10/2009 | US20090227762 Novel catalytic materials and their use in the preparation of polymeric materials |
09/10/2009 | US20090227629 Compounds having activity at the glycine transporter glyt1 and uses thereof |
09/10/2009 | US20090227592 Compounds effecting glucokinase |
09/10/2009 | US20090227591 Cyclopentene compounds |
09/10/2009 | US20090227585 Substituted n-heterocycle derivatives and methods of their use |
09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
09/10/2009 | DE202009007345U1 Neue Pharmazeutika und Arzneimittelzubereitungen New pharmaceuticals and pharmaceutical preparations |
09/09/2009 | EP2098510A1 Inhibitors for brassinosteroid signalling |
09/09/2009 | EP2098120A2 2-alkyl-cycloalk(en) yl-carboxamides |
09/09/2009 | EP2097382A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of no synthase |
09/09/2009 | EP2097381A1 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl)]carbamoyl}amino)-3-fluorophenox]-n-methylpyridine-2-carboxamide monohydrate |
09/09/2009 | EP2097380A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
09/09/2009 | EP2097379A1 Carboxamide derivatives as ion channel modulators |
09/09/2009 | EP2097378A1 Novel seh inhibitors and their use |
09/09/2009 | EP2097111A2 Heterodimers of glutamic acid |
09/09/2009 | EP1881958B1 Diacylglycerol acyltransferase inhibitors |
09/09/2009 | EP1809284A4 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
09/09/2009 | EP1397355B1 Pyridyl cyanoguanidine compounds |
09/09/2009 | CN101528701A Process for quenching gaseous reaction product containing cyanopyridine |
09/09/2009 | CN101528700A Process for the preparation of Imatinib and intermediates thereof |
09/09/2009 | CN101528699A Heterocyclic cetp inhibitors |
09/09/2009 | CN101528698A Novel salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine |
09/09/2009 | CN101525315A Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole |
09/09/2009 | CN100537539C Preparation method of 2-chlorin-6-trifluoro picoline |
09/09/2009 | CN100537538C Nove intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
09/09/2009 | CN100537537C Fungicidal composition comprising a pyridylethylbenzamide derivative and a compound capable of inhibiting the transport of electrons of the respiratory chain in phytopathogenic fungal organisms |
09/09/2009 | CN100537534C Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
09/09/2009 | CN100537527C Aryl and biaryl compounds having MCH modulatory activity |
09/09/2009 | CN100537523C Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease |
09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
09/08/2009 | US7585978 Processes of manufacturing substituted-1,4-dihydropyridines, improved aqueous solutions thereof, and processes of manufacturing the solutions |
09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
09/08/2009 | CA2416811C Production method of an ether compound |
09/08/2009 | CA2360360C Piperidyl benzamide compounds, composition containing same and their use thereof |
09/08/2009 | CA2314339C N-benzyl-3-indenylacetamide derivatives for treating neoplasia |
09/08/2009 | CA2141731C Antifungal agents, processes for the preparation thereof, and intermediates |
09/03/2009 | WO2009108657A2 Heteroaryl derivatives as cftr modulators |
09/03/2009 | WO2009107764A1 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens |
09/03/2009 | WO2009107651A1 Substituted bipyridyl compound and organic electroluminescent element |
09/03/2009 | WO2009107391A1 Compound having 6-membered aromatic ring |
09/03/2009 | WO2009106844A1 Inhibitors of p38 map kinase |
09/03/2009 | WO2009106825A1 Polymorphs of sorafenib and salts thereof |
09/03/2009 | WO2009106817A2 Compound |
09/03/2009 | WO2009106752A2 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereof and therapeutic application thereof |
09/03/2009 | WO2009106751A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
09/03/2009 | WO2009106750A2 Derivatives of 6-heterocyclic-imidazo[l,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
09/03/2009 | WO2009106749A2 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
09/03/2009 | WO2009106748A2 Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
09/03/2009 | WO2009106745A2 Method for enantio-selective preparation of sulphoxides |
09/03/2009 | WO2009106234A1 Process for preparing substituted biphenylanilides |
09/03/2009 | WO2009105906A1 Flavor molecules |
09/03/2009 | WO2009088220A3 N,n-dimethyl imidodicarbonimidic diamide nicotinate, method for producing the same and pharmaceutical composition comprising the same |
09/03/2009 | WO2009049845A3 Bisamide derivatives and their use as insecticidal compounds |
09/03/2009 | WO2008131860A3 Pyridonecarboxamides crop protection agents containing the same method for production and use thereof |
09/03/2009 | US20090221833 Polymorphic Form of Lercanidipine Hydrochloride and Process for the Preparation Thereof |
09/03/2009 | US20090221832 Process for preparing ketones from alpha-oxo carboxylates and aryl bromides |
09/03/2009 | US20090221817 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates |
09/03/2009 | US20090221699 Fab I Inhibitors |
09/03/2009 | US20090221640 Novel Crystal Modifications |
09/03/2009 | US20090221596 Substtituted aryl oximes |
09/03/2009 | US20090221591 Selective Inhibitors of Human Corticosteroid Synthases |
09/03/2009 | US20090221547 Immunosuppressant Compounds and Compositions |
09/03/2009 | US20090221546 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
09/03/2009 | US20090221424 Pesticides |
09/03/2009 | US20090220622 Use of mimosine or a derivative thereof for treating the cutaneous effects of psoriasis and related skin disorders, and cosmetic or pharmaceutical composition containing same |
09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
09/03/2009 | CA2716898A1 Compound having 6-membered aromatic ring |
09/03/2009 | CA2716647A1 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens |
09/03/2009 | CA2716109A1 Heteroaryl derivatives as cftr modulators |
09/03/2009 | CA2710962A1 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereef and therapeutic application thereof |
09/03/2009 | CA2710947A1 Derivatives of 6-heterocyclic-imidazo[1,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
09/03/2009 | CA2710943A1 Derivatives of n-phenyl-imidazo[1,2-.alpha.]pyridine-2-carboxamides, preon thereof and therapeutic application thereof |
09/03/2009 | CA2710860A1 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
09/03/2009 | CA2710794A1 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2-.alpha.]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
09/02/2009 | EP2096108A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same |
09/02/2009 | EP2096107A1 Derivatives of squaric acid with anti-proliferative activity |
09/02/2009 | EP2096104A1 Organic diamines as mGluR7 modulators |
09/02/2009 | EP2096101A1 Method for producing ketones from alpha-oxocarboxylates and aryl bromides |
09/02/2009 | EP2094684A2 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin 2-ones as cb1 receptor modulators |
09/02/2009 | EP2094663A2 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
09/02/2009 | EP2094662A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents |
09/02/2009 | EP2094661A2 Process for the preparation of atazanavir |
09/02/2009 | EP2094660A2 Immunochemically equivalent hiv drug analogs |
09/02/2009 | EP2094659A1 Heteroaryl (substituted) alkyl n-substituted sulfoximines as insecticides |
09/02/2009 | EP2094645A1 2-hydroxy-1,3-diaminopropane derivatives |
09/02/2009 | EP2094643A2 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
09/02/2009 | EP1856052B1 Nk1 antagonists |
09/02/2009 | EP1758860B1 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states |